| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| These changes in benign tumors are manifested by hyperproliferation ( EGFR ) , aberrant expression of keratinocyte genes ( PKC alpha and AP 1 ) and delayed terminal differentiation ( PKC delta ) . ^^^ |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| The elevation of PLD activity in response to inhibiting PKC delta , like transformation , was dependent upon PKC alpha and restricted to the EGFR cells . ^^^ |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| It is not active against kinases from other receptor families such as EGFR , FGFR 1 , c Met and Tie 2 or intracellular kinases like c Src , c Abl , PKC alpha . ^^^ |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| The Ang 2 induced proliferation of breast cancer cells was reduced by ( a ) G6976 , an inhibitor of conventional PKC alpha and beta 1 , ( b ) AG 1478 , an inhibitor of the tyrosine kinase of the EGF receptor ( EGFR ) , and ( c ) downregulation of 1 , 2 diacylglycerol sensitive PKCs achieved by phorbol 12 myristate 13 acetate ( PMA ) . ^^^ |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| The relative map positions of genes previously assigned to mouse chromosome 11 by somatic cell hybrid or genetic backcross analysis were determined ( Erbb , Rel , 11 3 , Csfgm , Trp 53 1 , Evi 2 , Erba , Erbb 2 , Csfg , Myhs , Cola 1 , Myla , Hox 2 and Pkca ) . ^^^ |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|
| Interacting proteins: P17252 and P00533 |
Pubmed |
SVM Score :0.0 |
| NA |
|